Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Return on Equity (2016 - 2025)

Akebia Therapeutics (AKBA) has disclosed Return on Equity for 10 consecutive years, with 0.14% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 154.0% to 0.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.14% through Dec 2025, down 154.0% year-over-year, with the annual reading at 0.64% for FY2025, 110.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.14% at Akebia Therapeutics, up from 0.45% in the prior quarter.
  • The five-year high for Return on Equity was 8.45% in Q1 2023, with the low at 14.3% in Q4 2022.
  • Average Return on Equity over 5 years is 0.69%, with a median of 0.3% recorded in 2025.
  • The sharpest move saw Return on Equity tumbled -1161bps in 2022, then surged 1579bps in 2023.
  • Over 5 years, Return on Equity stood at 2.69% in 2021, then plummeted by -431bps to 14.3% in 2022, then skyrocketed by 110bps to 1.48% in 2023, then fell by -6bps to 1.39% in 2024, then plummeted by -110bps to 0.14% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.14%, 0.45%, and 1.36% for Q4 2025, Q3 2025, and Q2 2025 respectively.